You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Patent: 7,186,753

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,186,753
Title:Pharmaceutical compounds
Abstract: Compounds or their salts of general formula (I): A--B--N(O).sub.s wherein: s is an integer equal to 1 or 2; A=R--T.sub.1--, wherein R is the drug radical and T.sub.1=(CO).sub.t or (X).sub.t\', wherein X=O, S, NR.sub.1c, R.sub.1c is H or a linear or branched alkyl or a free valence, t and t\' are integers and equal to zero or 1, with the proviso that t=1 when t\'=0; t=0 when t\'=1; B=--T.sub.B--X.sub.2--O-- wherein T.sub.B=(CO) when t=0, T.sub.B=X when t\'=0, X being as above defined; X.sub.2 is equal to R.sub.1B--X--R.sub.2B radical wherein X is as above defined, R.sub.1B and R.sub.2B, equal to or different from each other, are linear or branched C.sub.1 C.sub.6 alkylenes, or X.sub.2 is a radical wherein two alkylene chains C.sub.1 C.sub.4 are linked to nonadjacent positions of a central ring having 4 or 6 atoms, said ring being an unsaturated cycloaliphatic ring, or a saturated or aromatic heterocylic ring, containing one or two heteroatoms, equal or different, selected from O, S, N; wherein the unsaturated cycloaliphatic ring does not have aromatic character according to Huckel\'s rule.
Inventor(s): Del Soldato; Piero (Milan, IT)
Assignee: Nicox S.A. (Sophia Antipolis, FR)
Application Number:10/048,469
Patent Claims:see list of patent claims

Details for Patent 7,186,753

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Jubilant Hollisterstier Llc POSITIVE SKIN TEST CONTROL - HISTAMINE histamine INJECTION 103891 1 1995-06-15   Start Trial Nicox S.A. (Sophia Antipolis, FR) 2019-08-12 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.